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Abstract 1 
 2 
Penicillin-binding proteins (PBPs) have been scrutinized for over 40 years. Recent structural 3 
information on PBPs together with the ongoing long-term biochemical experimental investigations, 4 
and results from more recent techniques such as protein localization by GFP-fusion 5 
immunofluorescence or double-hybrid assay, have brought our understanding of the last stages of 6 
the peptidoglycan biosynthesis to an outstanding level that allows a broad outlook on the properties 7 
of these enzymes. Details are emerging regarding the interaction between the peptidoglycan-8 
synthesizing PBPs and the peptidoglycan, their mesh net-like product that surrounds and protects 9 
bacteria. This review focuses on the detailed structure of PBPs and their implication in 10 
peptidoglycan synthesis, maturation and recycling. An overview of the content in PBPs of some 11 
bacteria is provided with an emphasis on comparing the biochemical properties of homologous 12 
PBPs (orthologues) belonging to different bacteria.13 
 3 
Introduction 1 
 2 
The bacterial peptidoglycan not only enables the bacteria to resist the intracellular pressure 3 
of several atmospheres that exists in the cell but also provides the bacterium with a well defined 4 
cell-shape that is reproduced from generation to generation. The peptidoglycan is made of glycan 5 
chains of alternating N-acetylglucosamine and N-acetylmuramic acid cross-linked by short stem 6 
peptides attached to the N-acetylmuramic acid (Ghuysen, 1968, Schleifer & Kandler, 1972). PBPs 7 
catalyze the polymerization of the glycan strand (transglycosylation) and the cross-linking between 8 
glycan chains (transpeptidation). Some PBPs can hydrolyze the last D-alanine of the stem peptide 9 
(DD-carboxypeptidation) or hydrolyze the peptide bond connecting two glycan strands 10 
(endopeptidation). Endopeptidation and transpeptidation are reverse activities. Because of the 11 
structural resemblance between their natural substrate, the D-Ala-D-Ala end of the stem peptides, 12 
and penicillin, the late stage peptidoglycan synthesizing enzymes are sensitive to penicillin with 13 
which they form a long-lived acyl-enzyme that impairs their peptidoglycan cross-linking capability.  14 
 15 
 16 
Classification and overview of the content in PBPs of selected bacteria 17 
 18 
Bacteria possess a variable number of PBPs (figure 1). Since the sequencing of many 19 
bacterial genomes has been achieved, the number of PBPs of each bacterium is well determined. 20 
PBPs have been divided into two main categories, the high molecular mass (HMM) PBPs and the 21 
low molecular mass (LMM) PBPs. HMM PBPs are multimodular penicillin-binding proteins 22 
responsible for peptidoglycan polymerization and insertion into preexisting cell wall (Goffin & 23 
Ghuysen, 1998). Their topology consists of a cytoplasmic tail, a transmembrane anchor, and 24 
essentially two domains joined by a β-rich linker located in the outer surface of the cytoplasmic 25 
membrane where peptidoglycan synthesis takes place (Goffin & Ghuysen, 1998, Macheboeuf, et 26 
 4 
al., 2006, Lovering, et al., 2007). Depending on the structure and the catalytic activity of their N-1 
terminal domain, they belong either to class A or class B PBPs. The C-terminal penicillin-binding 2 
domain of both classes has a transpeptidase (TP) activity catalyzing peptide cross-linking between 3 
two adjacent glycan chains. In class A, the N-terminal domain is responsible for their 4 
glycosyltransferase activity, catalyzing the elongation of uncross-linked glycan chains. In class B, 5 
the N-terminal domain is believed to play a role in cell morphogenesis by interacting with other 6 
proteins involved the cell cycle (Holtje, 1998). Monofunctional enzymes (MGTs) similar to the 7 
glycosyltransferase (GT) domain of class A PBPs (A-PBPs) also exist in some bacteria but their 8 
exact role is still unknown (Spratt, et al., 1996). 9 
LMM PBPs are sometimes referred to as LMM PBPs of class A, B and C. As a whole LMM PBPs 10 
are frequently described with the general term of class C PBPs, sometimes with C1, C2 and C3 as 11 
subdivisions. We will use four subcategories and will refer to their main PBP representative in 12 
Escherichia coli, i.e. type-4 for PBPs similar to E. coli PBP4, type-5 for enzymes similar to E. coli 13 
PBP5, type-7 for PBPs similar to E. coli PBP7 and type-AmpH for PBPs similar to E. coli AmpH.  14 
The numbering of PBPs is historically based on SDS-PAGE migration and this may lead to some 15 
confusion. For example Staphylococcus aureus PBP2 is a class A PBP similar to E. coli PBP1a, S. 16 
aureus PBP3 is similar to E. coli PBP2 and S. aureus PBP1 is similar to E. coli PBP3. The 17 
complete set of PBPs of 10 important and widely studied bacteria, with their numbering and 18 
grouping in subclasses on the base of their sequence is provided in figure 1. The classification used 19 
herein is based on amino acid sequence alignment aided by the knowledge of structural features. 20 
The twelve PBPs of E. coli have been the subject of numerous investigations. E. coli 21 
possesses three class A PBPs. PBP1a and PBP1b are the major transpeptidases-transglycosylases. 22 
Deletion of one of them is not lethal for the bacteria (Suzuki, et al., 1978, Denome, et al., 1999, 23 
Meberg, et al., 2001). The role of PBP1c is not well understood. PBP1c is unaffected by most β-24 
lactams and overexpression of PBP1c does not suppress the autolysis phenotype of a mutant lacking 25 
both PBP1a and PBP1b(Schiffer & Holtje, 1999). The two class B PBPs of E. coli are 26 
 5 
monofunctional transpeptidases. PBP2 is involved in the elongasome, a putative complex specific 1 
to cell elongation while PBP3 is a major protein of the divisome, the cell division complex, (these 2 
complexes are dealt with in the chapter “Morphogenesis of the rod shaped sacculus” by den 3 
Blaauwen et al.). 4 
The seven LMM PBPs of E. coli are involved in cell separation, peptidoglycan maturation or 5 
recycling. PBP4 and PBP7 are two endopeptidases that cleave cross-bridges between two glycan 6 
strands. They probably should be considered as hydrolase members of the autolysins pool of E. coli 7 
(Vollmer & Holtje, 2004). PBP5 is the major carboxypeptidase, i.e. the most abundant, and it only 8 
cleaves the terminal D-Ala-D-Ala bond, making the stem peptide unavailable for transpeptidation. 9 
PBP6 and PBP6b both have sequences homologous to PBP5 and their activity is, like PBP5, that of 10 
a strict carboxypeptidase. PBP4b and AmpH both have a sequence close to the paradigmatic 11 
Streptomyces R61 DD-peptidase. The role of PBP4b is undetermined whereas AmpH is associated 12 
with peptidoglycan recycling.  13 
The Gram-negative Neisseria gonorrhoeae has only four PBPs. PBP1 is analogous to E. coli 14 
PBP1a (Ropp, et al., 2002) and PBP2 is homologous to E. coli PBP3 (Spratt & Cromie, 1988, 15 
Dowson, et al., 1989, Zhang & Spratt, 1989). Neisseria incorporates new peptidoglycan through its 16 
divisome complex. The absence of elongasome is coherent with the coccoïd shape of Neisseria. N. 17 
gonorrhoeae PBP3 and PBP4 have a sequence similar to E. coli PBP4 and PBP7, respectively 18 
(Stefanova, et al., 2003, Stefanova, et al., 2004). 19 
Bacillus subtilis is the model organism for sporulating Gram-positive bacteria. Most of its 20 
sixteen PBPs have been extensively studied for their role in vegetative peptidoglycan synthesis and 21 
in sporulation. B. subtilis has four class A PBPs. PBP1 is part of the cell division machinery and is 22 
required for the efficient formation of the asymmetric sporulation septum (Scheffers & Errington, 23 
2004). Among the six class B PBPs, PBP2b is the cell division specific class B transpeptidase 24 
(Daniel, et al., 2000). PBP4a is the equivalent of E. coli PBP4. PBP5 is the major carboxypeptidase. 25 
Two other carboxypeptidases similar to PBP5 are present in B. subtilis, PBP5* and dacF. PBP5* is 26 
 6 
required for proper spore cortex synthesis (Popham, et al., 1995) and dacF regulates the degree of 1 
cross-linking of spore peptidoglycan (Popham, et al., 1999). PBP4* and PBPX, two class C PBPs 2 
of type-AmpH, are supposed to be involved somehow in sporulation (Scheffers, 2005). Of note is 3 
the absence of type-7 PBP in B. subtilis. 4 
Staphylococcus aureus is a Gram-positive coccus. It incorporates peptidoglycan at the 5 
division site and has no elongasome. Consistantly its unique class A PBP localizes to the septum. 6 
Strains of S. aureus susceptible to β-lactam antibiotics have two class B PBPs (Pinho, et al., 2000, 7 
Pereira, et al., 2007) but resistant strains have acquired an additional PBP, PBP2a, with a low 8 
sensitivity to β-lactams. S. aureus has only one LMM PBP, which is of type-5 but unlike E. coli 9 
PBP5, S. aureus PBP4 has a transpeptidase activity necessary to achieve the high degree of cross-10 
linkage observed in the peptidoglycan of staphylococci (Wyke, et al., 1981). 11 
Listeria monocytogenes has six PBPs (Guinane, et al., 2006), including two class A PBPs (PBP1 12 
and PBP4), three class B PBPs (PBP2, PBP3 and lmo0441), and one class C PBP of type-5 (PBP5)  13 
(Vicente, et al., 1990, Korsak, et al., 2005, Zawadzka-Skomial, et al., 2006). Their respective role 14 
is not well known. Increased expression of PBP4 together with a histidine kinase was associated 15 
with resistance to nisin (Gravesen, et al., 2001, Gravesen, et al., 2004), an antibacterial peptide 16 
which exerts its action by forming pores in the cytoplasmic membrane through interaction with the 17 
PG precursor lipid II (Brotz, et al., 1998). 18 
Enterococcus faecalis has three class A and three class B PBPs (Arbeloa, et al., 2004). 19 
PBP4 is responsible for the resistance of E. faecalis to β-lactam antibiotics (Duez, et al., 2001).  As 20 
in most Gram-positive cocci, enterococci have one type-5 LMM PBP (el Kharroubi, et al., 1989). 21 
E. faecalis also possesses a type-AmpH PBP, similar to the PBPX of B. subtilis.  22 
Streptococcus pneumoniae has three class A PBPs (Hoskins, et al., 1999), two class B PBPs 23 
and a type-5 class C PBP (Morlot, et al., 2005). Unlike S. aureus, E. faecalis or L. monocytogenes, 24 
S. pneumoniae doesn’t have a penicillin-resistant PBP resembling S. aureus PBP2a and the 25 
 7 
resistance to β-lactams in S. pneumoniae arises from the alteration of the sequence and structure of 1 
its PBPs (Hakenbeck, 2000, Hotomi, et al., 2006).  2 
Probably because of their complex life cycle and their ability to produce β-lactam molecules 3 
(e.g. S. clavuligerus produces cephamycin and clavulanic acid (Ward & Hodgson, 1993)) the 4 
Actinomycetales of the Streptomyces genera have a great number of PBPs that can be expressed at 5 
the different stages of the bacterial development or when the bacterium effectively produces β-6 
lactam metabolites that can interfere with peptidoglycan biosynthesis. S. coelicolor has 21 PBPs: 7 
three class A, nine class B, and nine class C PBPs. The time schedule of their expression is 8 
unknown. 9 
Mycobacterium tuberculosis produces 2 class A PBPs, two class B PBPs and a lipoprotein 10 
sharing some motifs with the class B PBPs. It has also one type-4 PBP, one type-5 PBP and one 11 
type-7 PBP. Three type-AmpH putative PBPs complete the set of PBPs of M. tuberculosis. 12 
The cyanobacterium Anabaena sp. PCC7120 has twelve PBPs: six class A PBPs, two class 13 
B PBPs, two type-4 PBPs and two type-AmpH PBPs (Lazaro, et al., 2001, Leganes, et al., 2005). 14 
Strikingly, A. sp. is devoid of type-5 (and type-7) PBP a property shared by all cyanobacteria 15 
analysed by Leganes et al. 16 
 17 
 8 
The penicillin binding domain and the DD-peptidase activity 1 
 2 
PBPs share a common DD-peptidase activity, whether a DD-transpeptidase, a DD-3 
carboxypeptidase or a DD-endopeptidase activity (figure 2). The carboxypeptidation and 4 
transpeptidation reactions catalyzed by PBPs follow a three-step mechanism: the rapid reversible 5 
formation of a non covalent Henri-Michaelis complex between the enzyme and a peptidoglycan 6 
stem peptide, called the donor strand, is followed by the attack of the active serine on the carbonyl 7 
carbon atom of the C-terminal D-Ala-D-Ala peptide bond, leading to the formation of an acyl-8 
enzyme intermediate and the concomitant release of the C-terminal D-Ala (acylation). The final 9 
step (deacylation) consists in either hydrolysis, with release of the shortened peptidoglycan strand 10 
(carboxypeptidation), or cross-link formation with a second peptidoglycan stem peptide called the 11 
acceptor strand (transpeptidation). The DD-endopeptidase activity of PBPs consists in the 12 
hydrolysis of the cross-bridge resulting from the DD-transpeptidase activity. The endopeptidation is 13 
in fact a carboxypeptidation as it removes the last peptide of the stem pentapeptide. 14 
Carboxypeptidation is the term used for the removal by a PBP of the last D-alanine of the stem 15 
peptide and endopeptidation for the hydrolysis of the cross-bridge between two peptidoglycan 16 
strands. 17 
The DD-peptidase activity of PBPs is materialized by a common penicillin-binding (PB) 18 
domain, which binds β-lactam antibiotics (figure 2). The latter are aimed to inhibit the enzymatic 19 
DD-peptidase activity of the PB domain playing on the structural similarity between penicillin and 20 
the D-Ala-D-Ala dipeptide that ends the natural substrate of PBPs, the disaccharide pentapeptide. 21 
The PB domain of PBPs is made of two subdomains, a β-sheet covered by three α helices and an all 22 
helical domain. The active site lies at the interface of the two subdomains (figure 3A). There may 23 
be some flexibility between these two subdomains, and this can influence the binding capability of 24 
some PBPs towards various ligands (Lim & Strynadka, 2002). The active site encompasses nine 25 
residues broadly conserved in PBPs. The active serine is positioned at the beginning of helix α2 and 26 
 9 
is followed by a lysine to form a S*xxK motif. A second motif, SxN, is situated in a loop between 1 
helices α4 and α5. Four conserved residues form the third motif KTG(T/S). A ninth residue, a 2 
glycine situated in the rear of the active site, is also strictly conserved (figure 3A).  3 
Structural information regarding the interaction of PBPs with their substrate mainly comes 4 
from structures of LMM PBPs in complex with substrates that mimic the natural substrate. 5 
McDonough et al. obtained two high resolution structures with the DD-peptidase of Streptomyces 6 
R61, one showing the non-covalent binding of the two products of the carboxypeptidase reaction 7 
and the other showing the enzyme-substrate Henri-Michaelis complex resulting from the utilization 8 
of an inactivated enzyme (McDonough, et al., 2002). Nicola et al. reported a 1.6 Å resolution 9 
structure of E. coli PBP5 in complex with a substrate-like peptide boronic acid. The boronyl group 10 
mimics the transition state of a PBP-catalyzed deacylation reaction (Nicola, et al., 2005). We 11 
recently reported on the structure of B. subtilis PBP4a with α-aminopimelyl-ε-D-alanyl-D-alanine, 12 
a peptide that mimics the peptidoglycan ending tripeptide of Bacillus (Sauvage, et al., 2007). This 13 
structure shows the acyl-enzyme α-aminopimelyl-ε-D-alanyl-PBP4a and an unbound D-alanine, the 14 
result of the PBP-catalyzed acylation reaction. From these structures, it emerges that the 15 
penultimate D-alanine of the donor stem peptide fits tightly in the active site with its amide group 16 
wedged between the side chain of the asparagine of the second motif and the backbone of the β3 17 
strand that lines the active site (figure 3B). The carbonyl oxygen of the penultimate D-alanine lies 18 
in the oxyanion hole and its methyl group is inserted into a hydrophobic pocket, underlining the 19 
importance of the conserved glycine at the rear of the active site. The carboxylate of the leaving D-20 
alanine is oriented towards the two hydroxyl groups of the third motif. In brief, from the nine 21 
conserved residues, the asparagine of the second motif and both hydroxyl group of the third motif 22 
are important for the correct positioning of the substrate. The glycine of the third motif is needed to 23 
avoid sterical hindrance as a bulkier residue would block the entry of the active site to an incoming 24 
substrate. The glycine in the rear of the active site is important for the binding specifity of PBPs 25 
 10
towards the penultimate D-alanine of the peptidoglycan stem peptide (Adediran, et al., 2005). 1 
Finally, both serines and both lysines are important for the catalytic mechanism. 2 
 3 
Transpeptidase mechanism 4 
The acylation of PBPs by the penultimate D-alanine of the donor strand, with the 5 
concomitant release of the last D-alanine, requires the abstraction of a proton from the active serine. 6 
The lysine of the first motif, assumed deprotonated, can perform the withdrawal of the proton 7 
(Gordon, et al., 2000, Lim & Strynadka, 2002, Nicola, et al., 2005, Macheboeuf, et al., 2006, 8 
Sauvage, et al., 2007). The proton can subsequently be back-donated to the leaving D-alanine 9 
amine group via the serine of the second motif. Alternatively, the direct transfer of a proton from 10 
the active serine to the serine of the second motif concomitant to the transfer of a proton from the 11 
latter to the amine group of the leaving D-alanine in a one step process may be considered (Dive & 12 
Dehareng, 1999). 13 
In the deacylation step, a proton of the acceptor (an amino group in transpeptidation, water in 14 
carboxypeptidation) has to be abstracted to allow the activated group to attack the carbonyl carbon 15 
atom of the ester bond of the acyl-enzyme (Ghuysen, 1991, Goffin & Ghuysen, 1998). The proton 16 
can subsequently be back-donated to the active serine. Withdrawal of a proton from the acceptor 17 
group can be performed by the deprotonated serine of the second motif with the assistance of the 18 
lysine of the third motif (Nicola, et al., 2005).  19 
The active site of PBPs can be seen as a double lysine-serine system, one for acylation and one for 20 
deacylation, although both systems are not independent. Simple catalytic hydroxyl/amine dyads 21 
(Lys-Ser) are frequently encountered in proteins (Paetzel & Dalbey, 1997, Lee, et al., 2007). 22 
Withdrawal of a proton from the serine by the deprotonated lysine might be a too simplistic view. 23 
The proton must lie somewhere between the hydroxyl oxygen atom of the serine and the nitrogen 24 
atom of the lysine, and the resulting orientation of the lone pairs of the oxygen should be crucial for 25 
 11
the catalytic mechanism. Quantum level calculation on lysine-serine dyads is worth of 1 
consideration.  2 
 3 
Interaction with β-lactams 4 
PBPs are to a variable degree sensitive to β-lactam antibiotics, with which they form a stable 5 
acyl-enzyme. The acylation rates of benzylpenicillin with PBPs range from about 20 M-1s-1 for the 6 
penicillin-resistant class B PBPs (subclass B1) (Zorzi, et al., 1996, Lu, et al., 1999, Hujer, et al., 7 
2005) to  about 300.000 M-1s-1 in the case of type-4 PBPs (Granier, et al., 1992, Stefanova, et al., 8 
2003). 9 
Crystallographers have been successful in trapping acyl-enzymes of PBPs and β-lactam antibiotics. 10 
Most of the structures of PBPs have been solved in the apo form and in complex with β-lactams 11 
(Kuzin, et al., 1995, Gordon, et al., 2000, Lim & Strynadka, 2002, Sauvage, et al., 2002, 12 
Macheboeuf, et al., 2005, Nicola, et al., 2005, Sauvage, et al., 2005, Silvaggi, et al., 2005, Kishida, 13 
et al., 2006). X-ray structures show that many antibiotics covalently linked to the active site serine 14 
adopt a common standard positioning that shares some characteristics with the acyl-enzyme PBP4a-15 
α-aminopimelyl-ε-D-alanyl: (i) the amide group of the side chain is inserted between the asparagine 16 
of the second motif and the backbone of β3 strand, (ii) the carboxylate associated to the thiazolidine 17 
or to the dihydrothiazine ring of the antibiotic is hydrogen bonded to one or both hydroxyl groups 18 
of the KTGT motif, (iii) the carbonyl oxygen lies in the oxyanion hole. The acyl-enzyme PBP2a-19 
benzylpenicillin (Lim & Strynadka, 2002) is a typical example of this “canonical” conformation 20 
(figure 3C). The catalytic mechanism can follow the scheme described for PBPs with the D-Ala-D-21 
Ala end of the stem pentapeptide although a different mechanism can be at work.   22 
 12
Class A PBPs and MGTs 1 
 2 
Subclasses 3 
From sequence alignment, class A PBPs can be grouped in at least 7 subclasses (figure 1). 4 
As defined by Goffin & Ghuysen (Goffin & Ghuysen, 1998), subclasses A1 and A2 group Gram-5 
negative PBPs, whereas subclasses A3, A4, and A5 form three clusters of Gram-positive PBPs. 6 
Subclass A6 contains E. coli PBP1c and Anabaena sp. PBP2. The three S. coelicolor class A PBPs 7 
are grouped with the penicillin-resistant M. tuberculosis PBP1a in subclass A7. 8 
The presence of a class A PBP is necessary for cell growth in most but not all bacteria. Loss 9 
of E. coli PBP1a or PBP1b is tolerated but loss of both proteins is lethal even in the presence of 10 
PBP1c. Deletion of PBP1, the only class A PBP in N. gonorrhoeae, results in the loss of viability 11 
(Ropp, et al., 2002). In S. pneumoniae, the three class A PBPs are dispensable individually but 12 
PBP1a or PBP2a is required for growth in vitro (Hoskins, et al., 1999). 13 
The absence of all its class A PBPs is not lethal to B. subtilis. A strain lacking all four class 14 
A PBPs is still viable and produces a peptidoglycan with only small structural differences from that 15 
of the wild type. The growth rate of the quadruple mutant is much lower than that of a strain lacking 16 
only three of the class A PBPs and wall abnormalities are more frequent (McPherson & Popham, 17 
2003). PBP1 is mainly responsible for the morphological abnormalities (Popham & Setlow, 1995). 18 
A situation similar to the one observed in B. subtilis prevails in E. faecalis. Deletion of the three 19 
class A PBPs is not lethal although this leads to increase in generation time and decrease in 20 
peptidoglycan cross-linking. As there is no monofunctional glycosyltransferase in E. faecalis, the 21 
glycan chain polymerization in the triple mutant must be performed by a novel type of 22 
glycosyltransferase, that is not inhibited by moenomycin (Arbeloa, et al., 2004). 23 
In Gram-positive bacteria, the PBPs of subclass A3 are the major class A PBPs and are 24 
recruited to the septum site (Scheffers & Errington, 2004, Leski & Tomasz, 2005). Recruitment of 25 
 13
S. aureus PBP2 to the division site depends on its transpeptidation substrate (Pinho & Errington, 1 
2005). 2 
E. coli PBP1c is a penicillin-insensitive class A PBP. It binds only specific β-lactams and its 3 
transpeptidase activity could not be measured, which suggests that it may function in vivo as GT 4 
only. Interestingly, the pbpB gene coding for Anabaena sp. PBP2, a class A PBP with a sequence 5 
similar to E. coli PBP1c, is required for anaerobic nitrogen fixation in the cyanobacterium 6 
Anabaena sp strain PCC7120 (Lazaro, et al., 2001).. A PBP similar to PBP1c exists only in 7 
heterocyst-forming filamentous cyanobacteria (Leganes, et al., 2005). Anabaena sp PCC7120 has 8 
three class A PBPs similar to the three class A PBPs from E. coli and three additional class A PBPs 9 
similar to E. coli PBP1b (Lazaro, et al., 2001). 10 
 11 
Structural basis 12 
In their attempt to determine the structure of a class A PBP, the group of Dessen in Grenoble 13 
crystallized both PBP1a and PBP1b of S. pneumoniae (Macheboeuf, et al., 2005, Contreras-Martel, 14 
et al., 2006). In the same time, the group of Strynadka also solved the structure of PBP1b of S. 15 
pneumoniae (Lovering, et al., 2006). The structure of the transpeptidase domain associated with a 16 
linker domain could be determined but the structure of the transglycosylase domain remained 17 
undecephired. The determination of an X-ray structure of a class A PBP (S. aureus PBP2) with its 18 
transglycosylase domain was achieved recently by the group of Strynadka (Lovering, et al., 2007). 19 
The general fold of class A PBPs is made of a N-terminal domain coupled to the C-terminal 20 
penicillin-binding domain. The interdomain linker is composed of a small β-sheet, and one α helix 21 
(figure 4A). A small number of class A PBPs, e.g. the (penicillin-resistant) PBP1 of M. 22 
tuberculosis, contain an additional domain made of one or two repeating units known as PASTA 23 
domains  (Penicillin-binding protein And Serine/Threonine kinase Associated, because this domain 24 
is also found in the C-termini of serine/threonine kinases (Yeats, et al., 2002)). The PASTA domain 25 
is a small globular domain consisting of three β strands and one α helix. An Fn3 (fibronectin type 26 
 14
III) domain can also be found at the C-terminus of some class A PBPs whereas a FHA (forkhead-1 
associated) domain, consisting in a typical 11-stranded beta sandwich fold, may be found at the N-2 
terminus. This observation suggests a more complex organization and other functions acquired by 3 
these PBPs. The significance and role of these domains are still unknown, but most often Fn3 4 
domains are involved in some manner in cell surface binding and FHA domains are protein-protein 5 
interaction domains. 6 
 7 
Transpeptidase domain 8 
The global fold of the transpeptidase (TP) domain, as observed in PBP1a and PBP1b of S. 9 
pneumoniae and PBP2 of S. aureus, is identical to the general structure of the penicillin binding 10 
domaine described previously. However, both structures described for S. pneumoniae PBP1b show 11 
important conformational differences in the active site conformation of the apoenzyme. 12 
Macheboeuf et al. observed a “closed” active site in the absence of substrate or antibiotic 13 
(Macheboeuf, et al., 2005). Residues following the KTGT motif on strand β3 move away from 14 
strand β4 and an asparagine situated in the loop connecting these two strands makes hydrogen bond 15 
contacts with the backbone of a loop situated on the other side of the active site, thus blocking the 16 
entry of the active site. When crystals of PBP1b are grown in the presence of substrate, then washed 17 
and back-soaked in the presence of nitrocefin or cefotaxime, the active site retains a “canonical” 18 
configuration and the antibiotic forms with the PBP1b a classical acyl-enzyme. Analysis of the 19 
structure solved by Strynadka et al. reveals an ‘‘open’’ active site which  resembles the acyl-20 
enzyme active-site topology and is more similar to the one observed in the penicillin binding 21 
domain of other PBPs (Lovering, et al., 2006). It has been suggested that both observed apoenzyme 22 
structures may illustrate a conformational sampling of the ‘‘open’’ and ‘‘closed’’ forms that may 23 
play a regulatory role in PBP1b catalytic activity.  24 
 25 
Transglycosylase domain 26 
 15
Despite the difficulties of finding well behaved glycosyltransferases (GT), the efforts 1 
deployed by several laboratories led recently to the determination of two X-ray structures. The 2 
bifunctional S. aureus PBP2 (lacking the cytoplasmic and transmembrane anchor) was solved by 3 
Strynadka’s group (Lovering, et al., 2007) in apo form and in complex with moenomycin (figure 4 
4B), and the isolated GT domain of Aquifex aeolicus PBP1a was solved by Walker’s group (Yuan, 5 
et al., 2007). The two structures revealed that the GT domain contains almost only α-helices and its 6 
fold resembles that of λ-lysozyme but differs from all known GT structures. Like lysozyme the GT 7 
domain consists of a large and a small lobes separated by an extended cleft which contains the 8 
active site. The two structures differ in the small lobe, which of the GT is mainly α-helical and 9 
presents a hydrophobic region which probably mediates the interaction of the GT domain with the 10 
membrane while that of λ-lysozyme is hydrophilic and contains a β-sheet. Sequence alignments 11 
have revealed that all GT domains shared five conserved motifs. The first three motifs are found in 12 
the cleft. Motif 1 (EDxxFxxHxG) and motif 3 (RKxxE) contain the first and second putative 13 
catalytic glutamic acids respectively (figure4B). The essential glutamic acid in motif 1 of the GT 14 
and the catalytic Glu19 of λ-lysozyme are located at the same position. Motif 2 which divides the 15 
cleft in two pockets was proposed to be involved in substrate recognition. Motif 4 forms the back 16 
wall of the cleft and motif 5 is located in the large lobe farther from the active site. They were both 17 
suggested to play mainly structural role (Lovering, et al., 2007). Comparison of the ligand-free and 18 
moenomycin bound PBP2 structures shows that moenomycin induces conformational change in the 19 
small subdomain and that some flexibility occurs around the linker region connecting the GT and 20 
the TP domains.  21 
Monofunctional enzymes (MGTs) similar to the GT domain of class A PBPs also exist in 22 
some bacteria but their exact role is still unknown (Spratt, et al., 1996). Both the GT domain of A-23 
PBPs and MGTs belong to GT51 family which is characterized by the five conserved motifs and 24 
uses lipid II (undecaprenyl-P-P-MurNAc-(pentapeptide)-GlcNAc) as substrate. The MGTs 25 
represent about 20 % of the sequences in the GT51 database (CAZy.org) showing that the majority 26 
 16
of the GT are bifunctional PBPs. This proportion reflects the distribution and the number of class A 1 
PBPs and MGT among bacteria. 2 
 3 
Transglycosylation 4 
In class A PBPs, the N-terminal domain is responsible for their glycosyltransferase (GT) 5 
activity, catalyzing the elongation of uncross-linked glycan chains of the peptidoglycan. Their GT 6 
domain uses undecaprenyl-P-P-MurNAc-(pentapeptide)-GlcNAc lipid II as substrate. In recent 7 
years, a substantial progress has been made in the synthesis of lipid II (either radioactive or labeled 8 
with different fluorescent probes) using enzymatic route (van Heijenoort, et al., 1992, Breukink, et 9 
al., 2003), chemoenzymatic synthesis (Ye, et al., 2001, Schouten, et al., 2006) or complete 10 
chemical synthesis (Schwartz, et al., 2001, Schwartz, et al., 2002, VanNieuwenhze, et al., 2002). 11 
The availability of sufficient amount of fluorescent substrate allowed detailed kinetic 12 
characterization and additives (DMSO, detergent, metal ions) requirement of E.coli PBP1b GT 13 
activity (Schwartz, et al., 2002), the most biochemically characterized class A PBP.  14 
Several difficulties related to the intrinsic properties of the GT were though encountered 15 
during the purification and studies of these proteins. Most GT have a tendency to aggregate even in 16 
the presence of detergents and proteolysis was also often observed. In most cases the treatment of 17 
entire class A PBPs with trypsin results in stable transpeptidase domain and the complete 18 
degradation of the GT domain (Di Guilmi, et al., 1998, Di Guilmi, et al., 2003). It was shown that 19 
the expression of a stable class A PBPs GT domain greatly depends on the choice of the C-terminal 20 
boundaries (Barrett, et al., 2004). Finally, the numbers of GT that have been successfully purified 21 
and characterized (with kinetic parameters determined in vitro with lipid II) do not exceed a dozen 22 
candidates (Table 1).  23 
 24 
Properties of class A PBPs and GT domain  derivatives 25 
 17
E. coli PBP1a and 1b use monomeric -tri, -tetra and -pentapeptide as acceptor in the in vitro 1 
assay transpeptidase reaction with lipid II as substrate (Bertsche, et al., 2005, Born, et al., 2006). 2 
PBP1a catalyzes the polymerization of cross-linked peptidoglycan from lipid II with an efficiency 3 
of 33,000 M-1s-1 (Mottl, et al., 1995). The glycan strands have an average length of 20 disaccharide 4 
units with 18-26% of the peptides involved in cross-linking (Born, et al., 2006). In addition PBP1a 5 
catalyzes the attachment of nascent peptidoglycan to mature cell wall by transpeptidation (Born, et 6 
al., 2006). The catalytic efficiency of the PBP1b GT is 320,000 M-1s-1 (Schwartz, et al., 2002), and 7 
the length of glycan strands obtained by polymerization is superior to 25 disaccharide units with 8 
almost 50 % of the peptides engaged in cross-linking (Bertsche, et al., 2005). The activity of the 9 
two PBPs is inhibited by moenomycin (IC50 value for PBP1b are within 2-14 nM) (Terrak, et al., 10 
1999, Chen, et al., 2003, Welzel, 2005). Different GT domain derivatives of PBP1b were produced. 11 
They show similar moenomycin sensitivity and their catalytic activity is lower or comparable to 12 
that of the full length protein. For example, the fragments M46-D478 and M46-Q423 retain 23% 13 
and 13% of the entire PBP1b activity respectively (Terrak, et al., 1999). The C-terminal boundary 14 
of the GT domain was also identified between residues 385-478 (Barrett, et al., 2004). 15 
The full length PBP2 of S. aureus was purified and characterized with heptaprenyl-lipid II 16 
(C35) substrate. Its catalytic efficiency is 3,400 M
-1s-1. The PBP4 of L. monocytogenes EGD was 17 
overexpressed in E. coli and purified (Zawadzka-Skomial, et al., 2006). It catalyzes in vitro 18 
peptidoglycan polymerization with an efficiency of 1,400 M-1 s-1 from lipid II substrate. Disruption 19 
of the lmo2229 gene encoding PBP4 increased the resistance of L. monocytogenes EGD to 20 
moenomycin.  21 
S. pneumoniae PBP1a, PBP1b and PBP2a were overexpressed without transmembrane 22 
segment (∆tm) as GST fusions in E. coli, purified and characterized. GST-PBP2a∆tm fusion 23 
required detergent for solubility (Di Guilmi, et al., 1999) but not GST-PBP1b∆tm. A GT domain 24 
derivative of PBP1b (82-300) was also produced in the absence of detergent. These three proteins 25 
catalyze the polymerization of peptidoglycan from dansyl-lipid II substrate and the GT activity is 26 
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inhibited by moenomycin. Several observations suggest that moenomycin induces conformational 1 
modification of the GT domain (Lovering, et al., 2007). 2 
Since the expression of the full length PBP1a of A. aeolicus was poor (Yuan, et al., 2007), 3 
three derivatives of its GT domain (29/51/67-243) were realized and expressed in E. coli (Yuan, et 4 
al., 2007). The 67-243 derivative was active and catalyzes peptidoglycan polymerization from 5 
heptaprenyl lipid II with an efficiency of 10,000 M-1s-1. The glycan chains have a length of at least 6 
40 disaccharides. The 51-243 derivative leads to the X-ray structure solution. The role of residues 7 
Glu83, Asp84, H90 and K153 of the PBP1a GT domain was analyzed by mutagenesis. The results 8 
confirm the role of Glu83 as the catalytic glutamic acid residue of the GT51 family (Terrak, et al., 9 
1999, Terrak & Nguyen-Disteche, 2006). 10 
The GT domain of Thermotoga maritima PBP1a (Glu34–Thr244) was expressed and 11 
purified (Offant, et al., 2006). The use of detergents and/or moenomycin helped in reducing the 12 
aggregation state and increasing the protein homogeneity.  A glycosyltransferase activity was 13 
identified with fluorescent lipid II and was inhibited by moenomycin with an IC50 value of 14 
moenomycin was 4.8 µM. Mutagenesis experiments showed that Glu133 may be involved in 15 
catalysis. 16 
 17 
Properties of monofunctional glycosyltransferases 18 
A soluble and active form of S. aureus MGT was overexpressed in E. coli and purified 19 
(Wang, et al., 2001, Liu & Wong, 2006, Terrak & Nguyen-Disteche, 2006). The enzyme catalyzes 20 
glycan chain polymerization from lipid II with an efficiency of 5,800 M-1 s-1.  The properties of S. 21 
aureus MGT were more similar to those of E. coli PBP1b and distinct from those of S. aureus PBP2 22 
and E. coli MGT (Terrak & Nguyen-Disteche, 2006). A protein of ~34 kDa able to polymerize 23 
uncross-linked PG in vitro from lipid II substrate was isolated from E. coli (Hara & Suzuki, 1984). 24 
The membrane bound MGT was active but was insensitive to moenomycin (Di Berardino, et al., 25 
1996).  26 
 19
 1 
Glycosyltransferase mechanism 2 
The crystal structures of PBP2 and its complex with moenomycin, brought direct evidence 3 
that the lipid II is the acceptor and the growing chain is the donor (Lovering, et al., 2007). From the 4 
kinetic characterization of E. coli PBP1b (Schwartz, et al., 2002) and its interaction with 5 
moenomycin (Welzel, 2005), mutagenesis studies (Terrak, et al., 1999) and the recently determined 6 
crystal structure of S. aureus PBP2 (Lovering, et al., 2007), it was concluded that the mechanism of 7 
glycan chain elongation by the GT proceeds by successive attacks of the growing chain (donor) at 8 
the reducing end by lipid II (acceptor) catalyzed by deprotonation of the 4-OH nucleophile of 9 
GlcNAc by the active site base (Glu of motif 1), concomitant with stabilization of the leaving 10 
diphospho-undecaprenyl group by the second glutamate (motif 3) probably via a divalent metal 11 
(Schwartz, et al., 2002). The exact role of metal ion in the activity of the GT needs to be 12 
determined. It should be noted that apart from S. aureus PBP2 (Barrett, et al., 2005), the activity of 13 
most characterized GTs was dependent on metal ions (Schwartz, et al., 2002, Terrak & Nguyen-14 
Disteche, 2006, Zawadzka-Skomial, et al., 2006).  15 
 16 
Relation transglycosylation/transpeptidation in peptidoglycan synthesis 17 
For the bifunctional PBPs, the transglycosylation can proceed while the transpeptidase 18 
domain is either inhibited by penicillin, mutation or completely deleted (Terrak, et al., 1999, Born, 19 
et al., 2006). In contrast, inactivation of the glycosyltransferase domain by mutation (Terrak, et al., 20 
1999, Born, et al., 2006) or by moenomycin completely blocks the peptidoglycan polymerization. 21 
Study with E. coli PBP1a showed that, for the transpeptidation to occur, it must be coupled to the 22 
transglycosylase activity on the same polypeptide with stem donor peptide from oligomerized 23 
glycan strands (Born, et al., 2006). Time course of PG synthesis in vitro by PBP1a and PBP1b 24 
showed that peptide cross-linking catalyzed by PBP1b occurs simultaneously with GT of lipid II 25 
(Bertsche, et al., 2005). With PBP1a the transpeptidation is delayed until oligomerized glycan 26 
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strand are formed indicating that PBP1a transpeptidase prefers peptide of elongating glycan strands 1 
(Born, et al., 2006). 2 
 21
Class B PBPs 1 
 2 
Structural basis 3 
S. pneumoniae PBP2x was the first HMM PBP whose crystal structure was ever solved 4 
(Pares, et al., 1996). More recently, the structures of S. aureus PBP2a (Lim & Strynadka, 2002) and 5 
E. faecium PBP5 (Sauvage, et al., 2002) were solved at the same time. S. aureus PBP2a and E. 6 
faecium PBP5 are orthologous proteins responsible for the high level of resistance encountered in S. 7 
aureus and E. faecium strains. Sequence alignment allowed Goffin and Ghuysen (Goffin & 8 
Ghuysen, 1998) to define five subclasses. S. aureus PBP2a and E. faecium PBP5 are in the subclass 9 
B1 and all the PBPs in this subclass are supposed to show a low affinity for penicillin. The subclass 10 
B2 contains elongasome specific type-2 PBPs of Gram-negative bacteria (e.g. E. coli PBP2), 11 
whereas the subclass B3 contains divisome specific type-3 PBPs of Gram-negative bacteria (e.g. E. 12 
coli PBP3). S. pneumoniae PBP2x is part of subclass B4 together with other enzymes involved in 13 
division of Gram-positive bacteria, and subclass B5 contains enzymes from Gram-positive not 14 
directly involved in septation. Subclasses B-like I, II and III are defined by Goffin & Ghuysen 15 
(Goffin & Ghuysen, 2002) and contains PBPs from mycobacteria, streptomycetes, and related 16 
bacteria. 17 
The overall fold of class B PBPs is made of a complex N-terminal domain coupled to the C-18 
terminal transpeptidase domain. In the transpeptidase domain, the residue following motif 3 19 
(KTG(T/S)) is, with very few exceptions, an alanine in class B PBPs (KTG(T/S)A) while it is a 20 
threonine or a serine in class A PBPs (KTG(T/S)(T/S)), and this might be related to their specific 21 
role as class A or class B PBPs. Gram-negative type-2 PBPs are also distinguished in their active 22 
site by the presence of an aspartic acid at the third position of motif 2 (SxD). The other subclasses 23 
have an asparagine as in the canonical active site of PBPs (SxN).  24 
 22
The N-terminal domain was hypothesized to interact with other proteins (Holtje, 1998) or to 1 
serve as a pedestal for PBPs to reach their target (Macheboeuf, et al., 2006). Small loops or 2 
domains may interact with other proteins as shown by a complementation analysis of the PBP3 3 
deficiency in E. hirae (Leimanis, et al., 2006). The interdomain linker is made of four to six β-4 
strands. Five conserved motifs (I to V) in or close to the linker constitute the signature of class B 5 
PBPs (Goffin & Ghuysen, 1998).  The N-terminal domain should be seen as small subdomains or 6 
loops that are connected to the interdomain linker (figure 5). The number of residues in each loop or 7 
subdomain between the conserved motifs is characteristic of each subclass. In the absence of a type-8 
2 PBP structure, the features distinguishing E. coli PBP2 from E. coli PBP3 are unknown. 9 
Interestingly, in Gram-negative bacteria, the length of the loop between motif II and motif III is 10 
similar in all type-2 PBPs and in all type-3 PBPs but differs between type-2 and type-3. This holds 11 
as well for the loop between motif IV and motif V, but the significance of such characteristics 12 
awaits further structural information. 13 
The length of the loop between motif III and motif IV (figure5) is similar in subclasses B1 14 
and B2. As well, the loop between motifs IV and V and the loop between motif V and motif 1 of 15 
the transpeptidase domain are of same length in subclasses B1 and B2 whereas they have different 16 
length in the other subclasses. Sequence alignment suggests that enzymes of subclass B1 are the 17 
equivalent in Gram-positive bacteria of E. coli PBP2 but experimental evidence with B. subtilis 18 
PBP2a and PBPH suggests rather that the equivalent of Gram-negative type-2 PBPs are enzymes of 19 
subclass B5 (Murray, et al., 1998, Wei, et al., 2003).  20 
 21 
Role of class B PBPs in peptidoglycan biosynthesis 22 
B. subtilis PBP2a is required for normal outgrowth of spores (Murray, et al., 1998). PBP2a 23 
and PBPH play redundant roles in determining the rod cell shape and the activity of one of these 24 
proteins is required for viability (Wei, et al., 2003). In the double mutant, septa are formed 25 
extremely irregularly and cells have a greater diameter (Wei, et al., 2003), a phenotype also 26 
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associated with the loss of PBP5 (Nelson & Young, 2000). PBPH is expressed most strongly in late 1 
log phase and during the transition to stationary phase and may play a unique role during that part 2 
of the life cycle.  3 
In Gram-positive cocci, the situation is different. There is no apparent phenotype associated 4 
with the inactivation of pbp3 (PBP3) in S. aureus regarding growth rate, cell wall muropeptide 5 
profile, and impact on methicillin resistance in a MRSA strain. The only observable effect was a 6 
decrease in autolysis rate (Pinho, et al., 2000).  The problem of the presence of two or three class B 7 
PBPs in Gram-positive cocci and the role of class B PBPs not involved in bacterial division is 8 
addressed by Zapun et al in the chapter “The different shapes of cocci”. 9 
Gram-positive division specific PBPs belong to subclass B4. They all possess a supplementary 10 
domain made of two repeating units known as PASTA domains (cf class A PBPs). An interesting 11 
example is the serine/threonine kinase PknB of M. tuberculosis that phosphorylates PBPA, a class 12 
B PBP required for cell-division (Dasgupta, et al., 2006). The PASTA domain is believed to bind 13 
unlinked peptidoglycan because a cefuroxime was observed associated to the first PASTA domain 14 
in the X-ray structure of S. pneumoniae PBP2x (Gordon, et al., 2000) but further experimental 15 
evidence is needed to prove this assertion. 16 
M. tuberculosis has one type-3 PBP (pbpB or mtu3), one in subclass B-like I (PBPA) and one in 17 
subclass B-like II, which is annotated as Penicillin-binding lipoprotein. S. coelicolor has one PBP 18 
(“PBP2”, sco2608) classified in subclass B2, but with a weak similarity to other members and one 19 
in subclass B3 (“PBP3”, sco2090). S. coelicolor has also four B-like I and three B-like III PBPs. 20 
Anabaena sp. PCC7120 has one type-2  PBP (PBP5; alr5045) and one type-3 PBP (PBP6; 21 
alr0718). Their sequences are close to those of their respective E. coli orthologues. The roles of 22 
these proteins are largely unknown. 23 
 24 
Resistance to β-lactams 25 
 24
Class B PBPs play an important role in the resistance to β-lactams of many bacteria. One 1 
resistance mechanism found in some Gram-positive bacteria is the presence of an endogenous or 2 
acquired penicillin-resistant PBP that can take over the transpeptidase function of all other PBPs, 3 
like S. aureus PBP2a and E. faecium PBP5. Strikingly a similar PBP in L. monocytogenes 4 
(lmo0441) is responsible for the resistance to monobactams and some cephalosporins but not 5 
penicillin (Guinane, et al., 2006). 6 
Mutations or mosaic gene transfer is also frequently observed with naturally competent 7 
bacteria, mainly involving the division specific class B PBP (type-3 PBP). Alterations of the N. 8 
gonorrhoeae or meningitidis PBP2 (a type-3 PBP) is associated with reduced susceptibility to 9 
penicillin G (Dougherty, et al., 1980, Barbour, 1981, Spratt, 1988, Antignac, et al., 2001), a 10 
situation that also exists in Pseudomonas aeruginosa, S. pneumoniae and Bacteroides fragilis 11 
(Ayala, et al., 2005). This situation also occurs in class A PBPs. For example, alterations in 12 
penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori 13 
(Kwon, 2003). (see chapter “Penicillin-Binding Proteins and -lactam resistance” by Zapun et al.) 14 
 25
Class C PBPs of type-4 1 
 2 
Structural basis 3 
There is generally one or zero type-4 class C PBP in bacteria. Of note is the absence of this 4 
type of protein in Gram-positive cocci like staphylococci, enterococci, streptococci or listeria. S. 5 
coelicolor and some cyanobacteria are the only presumably known bacteria possessing two type-4 6 
PBPs.  7 
The three X-ray structures of type-4 PBPs available to date show a great similarity in their 8 
overall folding (Sauvage, et al., 2005, Kishida, et al., 2006, Sauvage, et al., 2007) (figure 6). The 9 
transpeptidase domain is associated with two other domains, which are not in N- or C-terminal 10 
positions but are inserted in the transpeptidase domain in the way of matryoschka dolls (Sauvage, et 11 
al., 2005), i.e. the third domain is inserted in the second domain, which itself is inserted in the 12 
penicillin-binding domain between the conserved motifs 1 and 2 (of the PB domain). The role of 13 
these domains is unknown. Domain II has the topology of half a Rossmann fold, which is also the 14 
case of the N-terminal domain MinC and the 1A region of FtsA, two proteins interacting with FtsZ 15 
and involved in the regulation of the septum formation in cell division, but the resemblance of these 16 
proteins to the domain II of type-4 PBPs remains limited (Sauvage, et al., 2005). Interestingly a 17 
positively charged surface appears in domain II of the DD-peptidase of Actinomadura R39 and B. 18 
subtilis PBP4a (figure 6), and it has been suggested that this positive surface could interact with the 19 
teichoic acid present in Bacillus and Actinomycetales (Sauvage, et al., 2007). 20 
Strikingly, the number of residues between motifs 1 and 2 is reduced by 50 for type-4 PBPs of 21 
some bacteria (Streptomyce  avermitidilis, S. coelicolor, Corynebacterium diphtheriae, M. 22 
tuberculosis, Anabaena sp (PBP11 but not PBP10), …), which corresponds approximatively to the 23 
length of the sequence of domain III and our sequence alignment supports the idea that this domain 24 
is absent from those bacteria. 25 
 26
The surroundings of the active site are specific to type-4 PBPs. The residue following motif 1 
3 is invariably a leucine or a methionine, a hydrophobic residue turned inside the cavities that 2 
pushes the C-terminus of β3 strand slightly in the forefront of the active site. Together with residues 3 
pertaining to domain II, the residues of the C-terminus of β3 strand form a pocket that can 4 
accommodate the terminal H3N+-CH-COO- group of the diaminopimelic acid, the antepenultimate 5 
amino-acid of the peptidoglycan stem peptide (Sauvage, et al., 2007). The residues involved in the 6 
binding pocket are widely conserved with some variations (Sauvage, et al., 2005). 7 
Type-4 LMM PBPS have medium to high β-lactam binding activities (Duez, et al., 2001, 8 
Stefanova, et al., 2003). High acylation rates and very low deacylation rates make them good 9 
candidates to trap crystallographic acyl-enzyme with β-lactams or other interacting ligands (Jamin, 10 
et al., 1991, Sauvage, et al., 2005, Kishida, et al., 2006, Sauvage, et al., 2007) (unpublished results 11 
with Actinomadura R39).  12 
 13 
Role of type-4 PBPs in peptidoglycan biosynthesis 14 
Type-4 PBPs are not anchored into the cytoplasmic membrane via a transmembrane helix 15 
(Harris, et al., 2002, Stefanova, et al., 2003) (Gittins, et al., 1994, Harris, et al., 2002). Nearly all of 16 
E. coli PBP4 in overproducing cells is in a soluble form (Korat, et al., 1991, Gittins, et al., 1994). 17 
N. gonorrhoeae PBP3 has been identified to an outer membrane protein that interacts with 18 
peptidoglycan (Judd, et al., 1991, Shafer & Judd, 1991). The DD-peptidase of Actinomadura R39 is 19 
found in the culture medium, and B. subtilis PBP4a is easily washed away from the cells with a 20 
buffer containing 1M KCl (C. Duez, personal communication). These results suggest that type-4 21 
PBPs are very loosely associated with the cytoplasmic membrane. They could be associated directly 22 
with the peptidoglycan as suggested for PBP4a. Gram-positive type-4 PBPs could interact with 23 
anionic polymers that decorate the peptidoglycan whereas Gram-negative type-4 PBPs could be 24 
associated with the outer membrane or directly with the peptidoglycan. 25 
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Localization studies by green fluorescent protein fusions have shown that B. subtilis PBP4a 1 
is recruited to the lateral wall and is absent from the septum (Scheffers, et al., 2004). This result 2 
must be paralleled with the presence of a type-4 PBP in N. gonorrhoeae, a coccoïd bacterium 3 
without lateral wall. 4 
An in vivo endopeptidase activity has been shown for E. coli PBP4 (Korat, et al., 1991) and N. 5 
gonorrhoeae PBP3 (Stefanova, et al., 2003). Type-4 PBPs are dispensable under laboratory growth 6 
conditions (Duez, et al., 2001, Stefanova, et al., 2003) but an endopeptidation function might be 7 
necessary for correct peptidoglycan incorporation and cell growth.  8 
The absence of a membrane anchoring helix and the in vivo endopeptidase activity are two 9 
arguments in favour of type-4 PBPs being envisioned as members of the pool of autolysins, as 10 
suggested by Höltje and colleagues for E. coli. Type-4 PBPs could be inserted into the 11 
peptidoglycan or exposed on the outer face of peptidoglycan where it would exert its endopeptidase 12 
activity. It could thereby be indirectly involved in cell morphology (Meberg, et al., 2004), in 13 
daughter cells separation (Priyadarshini, et al., 2006), and could be implicated in biofilm formation 14 
(Gallant, et al., 2005). 15 
 16 
 17 
 18 
 19 
 20 
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Class C PBPs of type-5  1 
 2 
We distinguish the groups of type-5 and type-7 class C PBPs on the basis of the presence in 3 
type-5 PBPs of a C-terminal domain that was shown in E. coli to be essential for the correct 4 
functioning of the PBP5 (Nelson & Young, 2001). The PBP5 C-terminal domain ends with an 5 
amphipathic helix that associates PBP5 to the cytoplasmic membrane. The truncated PBP5, lacking 6 
the C-terminal domain, is soluble (like PBP7) and its overproduction leads to cell lysis (Nelson & 7 
Young, 2001).  8 
 9 
Structural basis 10 
The crystal structures of E. coli PBP5 (Davies, et al., 2001, Nicholas, et al., 2003), S. 11 
pneumoniae PBP3 (Morlot, et al., 2005) and S. aureus PBP4 have been determined (figure 7A). 12 
The overall fold of type-5 PBPs is biglobular. The penicillin binding domain is associated with a β-13 
strand rich C-terminal domain that ends with an associated membrane amphipathic helix. The 14 
penicillin binding domain lacks the N-terminal helix and a small loop extends on the top of the 15 
active site. 16 
 17 
Role of type-5 PBPs in peptidoglycan biosynthesis 18 
With the exception of S. aureus PBP4, type-5 PBPs are strict DD-carboxypeptidases unable 19 
to catalyze a transpeptidation reaction (Matsuhashi, et al., 1979). They play a major role in the 20 
control of cell diameter and correct septum formation. Cells of an E. coli mutant lacking only PBP5 21 
had aberrant morphology (Meberg, et al., 2004), exacerbated by the deletion of other DD-22 
carboxypeptidases (Nelson & Young, 2000, Nelson & Young, 2001). In L. monocytogenes, cells 23 
lacking PBP5 displayed an irregular morphology and shape (Guinane, et al., 2006), and a thicker 24 
cell wall (Korsak, et al., 2005). Moreover the ratio of pentapeptides to tripeptides was increased in 25 
cells lacking PBP5 (Korsak, et al., 2005). The ratio of pentapeptides to tripeptides was also largely 26 
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increased in a dacA (PBP5) mutant of B.subtilis (Atrih, et al., 1999). In S. pneumoniae, PBP3 plays 1 
a major role in organizing the growth and division process (Morlot, et al., 2004). PBP3 is present 2 
on the whole surface of the cell except at the septum, where the pentapeptides are left intact as 3 
substrates of the division specific PBPs.  4 
In contrast to previous results, S. aureus PBP4 was shown to have a secondary 5 
transpeptidase activity (Wyke, et al., 1981). Disruption of pbpD, the structural gene of S. aureus 6 
PBP4, caused a large decrease in the highly cross-linked muropeptide components of the cell wall 7 
(Leski & Tomasz, 2005).  The striking difference between the activity, function and physiological 8 
role of S. aureus PBP4 compared to the concordant activity, function and physiological role of its 9 
structural equivalent in other bacteria remains to be explained. A possibility is that S.aureus PBP4 10 
plays a similar role in restricting the availability of pentapeptides to its division specific PBPs, but 11 
instead of simply removing the ultimate D-alanine of the stem peptide, PBP4 utilizes the available 12 
D-Ala-D-Ala to further cross-link the glycan chains. 13 
Bacteria most often have a major type-5 PBP which is the most abundant LMM PBP they 14 
produce. E. coli produces two other type-5 PBPs (figure 1). The expression level of E. coli PBP6 15 
considerably rises in stationary-phase cells compared with exponentially growing cells(Buchanan & 16 
Sowell, 1982). The level of transcription of dacA (PBP5), dacC (PBP6) and ampC (AmpC) is 17 
controlled by the bolA gene (Santos, et al., 2002). PBP6 is supposed to play a major role at the 18 
onset of stationary-phase (van der Linden, et al., 1992). Interestingly, by constructing mosaic 19 
proteins in which a 20 amino-acids sequence were grafted from PBP5 to PBP6, and vice versa, 20 
Ghosh and Young showed that the shape maintaining characteristics of PBP5 relies on residues 21 
following the KTGT motif (Ghosh & Young, 2003). 22 
B subtilis produces three type-5 PBPs (figure 1). PBP5 (dacA) is the major carboxypeptidase 23 
found in vegetative cells (Lawrence & Strominger, 1970). PBP5 has no role in spore peptidoglycan 24 
synthesis but PBP5* (dacB) and DacF (dacF) both function in regulating the degree of cross-25 
linking of spore peptidoglycan (Popham, et al., 1999). dacB is expressed only in the mother cell 26 
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compartment of the developing sporangium whereas dacF is expressed in the forespore 1 
compartment and they can act differently on the nascent spore peptidoglycan (Popham, et al., 2 
1999). 3 
 31
Class C PBPs of type-7  1 
 2 
As we mention for type-5 PBPs, E. coli PBP7 and E. coli PBP5 have homologous 3 
sequences. The structure of PBP7 differs from that of PBP5 by the absence of the C-terminal 4 
domain and the amphiphatic helix that anchors PBP5 to the cytoplasmic membrane. 5 
 6 
Structural basis 7 
The crystal structures of Mycobacterium tuberculosis PBP7 (Krieger, unpublished) and the 8 
DD-peptidase of Streptomyces K15 (Fonzé, et al., 1999) (K15) have been determined. The 9 
sequence of K15 is slightly different from the sequences of the other type-7 PBPs (Palomeque-10 
Messia, et al., 1991) and close orthologues have been found only in S. coelicolor and S. 11 
avermitidilis. The global fold of M. tuberculosis PBP7 and K15 proteins is similar to the penicillin-12 
binding domain of E. coli PBP5. As type-5 PBPs, type-7 PBPs lack the N-terminal helix and exhibit 13 
on the top of the active site a β-hairpin protuberance, which in K15 is relatively long and was 14 
hypothesized to anchor the protein to the plasma membrane (Fonzé, et al., 1999) (figure 7B). 15 
 16 
Role of type-7 PBPs in peptidoglycan biosynthesis 17 
E. coli PBP7 was shown to be loosely associated with the membrane and totally released in 18 
the supernatant in the presence of 1M NaCl (Romeis & Holtje, 1994). PBP7 is an endopeptidase 19 
that hydrolyses the D-alanyl-ε-meso-2,6-diaminopimelyl cross-bridge bond in high-molecular mass 20 
sacculi (not with soluble low molecular mass muropeptides) but had no carboxypeptidase activity. 21 
Interestingly, a mutant of E. coli lacking PBP7 showed no morphological change but a double 22 
mutant ∆PBP5-∆PBP7 was more abnormal than the single mutant lacking only PBP5 (Meberg, et 23 
al., 2004). E. coli PBP8, a proteolytic degradation product of PBP7, was also shown to stabilize the 24 
soluble lytic transglycosylase Slt70, and indirectly interact with PBP3 (Romeis & Holtje, 1994). As 25 
we suggsested for type-4 PBPs, E. coli PBP7 should probably be looked at as an autolysin but its 26 
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precise role remains unclear and the difference between the role of E. coli PBP4 and the role of E. 1 
coli PBP7 is undetermined. Both are endopeptidases implicated in cell morphology (Meberg, et al., 2 
2004) and in daughter cells separation. 3 
N. gonorrhoeae PBP4 is close to E. coli PBP7. It lacks the characteristic C-terminal domain 4 
of type-5 PBPs. PBP4 has a carboxypeptidase activity on L-Lys-D-Ala-D-Ala based substrates, 5 
preferentially with Nε substituted substrates. It showed no transpeptidase activity in a 6 
transpeptidation reaction with Ac2-L-Lys-D-Ala-D-Ala as donor and glycine as acceptor. 7 
Endopeptidation was not tested. One of the two LMM PBPs (PBP3 or PBP4) can be deleted 8 
without severely affecting the cells but the removal of both of them leads to a modest decrease of 9 
cell growth and a change in morphology, suggesting that N. gonorrhoeae PBP3 and PBP4 have a 10 
redundant function in normal cell wall biosynthesis (Stefanova, et al., 2004).  11 
Type-7 PBPs are absent from the Gram-positive bacteria that we have analyzed, with the exception 12 
of the vanYD DD-carboxypeptidase (Arthur, et al., 1994, Casadewall, et al., 2001, Reynolds, et al., 13 
2001). The vanYD DD-carboxypeptidase is included in the vanD gene cluster responsible for the 14 
resistance to vancomycin of enterococci (Courvalin, 2006). VanYD lacks the C-terminal domain of 15 
E. coli PBP5 and hence cannot be associated with the membrane via the C-terminal amphiphatic 16 
helix characteristic of type-5 PBPs. The hydrophobicity profile of VanYD rather suggests that there 17 
is a single transmembrane segment close to the N-terminus (Reynolds, et al., 2001).  18 
The in vivo endopeptidation activity and the carboxypeptidation/transpeptidation activities might 19 
result from the location of the protein active site at the outer face (endopeptidase) or inner face 20 
(carboxypeptidase/transpeptidase) of the peptidoglycan. 21 
 Although lacking transmembrane segments, S. K15 enzyme is associated with the 22 
cytoplasmic membrane. Its overexpression results in the secretion of ~30% of the synthesized 23 
enzyme in the culture medium. K15 can be considered as a strict transpeptidase, for which the rate 24 
of transpeptidation depends on the nature of both the scissile bond (peptide, thiolester, or ester) of 25 
the carbonyl donor and the acceptor. When assayed on Ac2-L-Lys-D-Ala-D-Ala, the enzyme 26 
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behaves as a poor hydrolase. It utilizes the small amount of the released D-Ala as an acceptor to 1 
catalyze a silent exchange between the tripeptide C-terminal D-Ala and the free amino acid. In the 2 
presence of Gly-Gly or Gly-L-Ala, which mimic the structure of the acceptor in the nascent 3 
peptidoglycan, virtually no hydrolysis product is formed, and the enzyme behaves as a strict and 4 
efficient transpeptidase (Nguyen-Disteche, et al., 1982, Fonzé, et al., 1999).  5 
 6 
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Class C PBPs of type-AmpH 1 
 2 
Structural basis 3 
The structure of type-AmpH PBPs is mainly based on the structure of the DD-peptidase of 4 
Streptomyces R61 (R61) (reviewed in (Frère, 2004)). R61 folding is similar to the PB domain 5 
described for the other classes of PBPs although differences occur in loops or even secondary 6 
structures (figure 8A). The active site lies at the interface of the two subdomains and the first motif 7 
SxxK is similar to other PBPs. The conserved serine of the second motif (SxN) is, in type-AmpH 8 
PBPs, replaced by a tyrosine and this is the main feature that distinguishes the enzymes of this 9 
family. Nevertheless, when superposing the active site of R61 to that of other PBPs, the tyrosine 10 
hydroxyl group of R61 is roughly at the same position as the hydroxyl group of the serine of the 11 
second motif of the other PBPs. The third residue of the second motif is generally an asparagine but 12 
is an aspartic acid in E. coli PBP4b. The third motif (KTG(T/S)) is not well conserved in this 13 
family. A histidine is frequently found at the first position but a lysine can also occur, as in E. coli 14 
AmpH. The second position also suffers variations. An arginine and a serine residue are 15 
respectively found in the two type-AmpH PBPs (PBP9 and PBP12) of the cyanobacterium 16 
Anabaena sp. PCC7120, whereas the type-AmpH PBP of E. faecalis have a HGG motif.   17 
The exact enzymatic function of these enzymes is generally not determined except in a few 18 
cases and we cannot be sure that these proteins have a role in peptidoglycan biosynthesis or that 19 
they have another function, for example a β-lactamase function or a D-aminopeptidase function. A 20 
D-amino acid amidase from Ochrobactrum anthropi was shown to have a fold similar to that of 21 
R61 (Bompard-Gilles, et al., 2000, Okazaki, et al., 2007). Because a loop impairs its active site 22 
entrance, the D-aminopeptidase lacks transpeptidase and carboxypeptidase activities (figure 8B). 23 
 24 
Class C β-lactamases 25 
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Class C β-lactamases also have a structure close to R61, and although β-lactamases are not 1 
included in our analysis of penicillin-binding proteins, we will briefly discuss them because it has 2 
been suggested that the AmpC β-1actamase may have an additional cellular function as a 3 
peptidoglycan hydrolase (Bishop & Weiner, 1993, Henderson, et al., 1997). From the high 4 
structural similarity, first observed between R61 and the class C β-lactamase of Enterobacter 5 
cloacae P99, has emerged the hypothesis of an evolution from a common ancestral enzyme. The 6 
evolution scenario includes structural changes leading in β-lactamases to rejection of the D-methyl 7 
substituent of the penultimate D-alanine residue of the DD-peptidase substrate. However molecular 8 
modelling studies have shown that the D-alanyl methyl group fits tightly into the space originally 9 
occupied by the motif 2 tyrosine side chain and thus allows the bound substrate to adopt a 10 
conformation similar to that observed in the R61 active site, which has a hydrophobic pocket for 11 
this substituent. Accommodation of the penultimate D-alanyl methyl group seems therefore to be 12 
necessary, but not sufficient for an efficient DD-peptidase activity (Adediran, et al., 2005). 13 
In E. coli, ampC deletion mutant exhibited a decline in growth rate at mid-exponential phase 14 
which could be delayed by expression of AmpC at early-exponential phase. Maintenance and 15 
expression of the ampC gene represents an unbearable cost for Salmonella enterica in terms of 16 
reduction of the growth rate and invasiveness (Morosini, et al., 2000). The deleterious AmpC 17 
burden could be eliminated by decreasing the production of AmpC when both regulatory ampR and 18 
ampC genes were present in S. enterica. Even if AmpC synthesis did not produce major variations 19 
in the peptidoglycan composition of S. enterica, data suggested that overexpression may interfere 20 
with normal PG synthesis or turnover. 21 
 22 
Role of type-AmpH PBPs in peptidoglycan biosynthesis 23 
Although closely related to AmpC and other class C β-lactamases, and despite the fact that 24 
they strongly bind penicillin, AmpH and Pbp4b show no β-lactamase activity (Henderson, et al., 25 
1997, Vega & Ayala, 2006). Mutation of the ampC and/or ampH genes in E. coli lacking PBPs 1a 26 
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and 5 produced morphologically aberrant cells, particularly in cell filaments induced by aztreonam. 1 
Thus, these traits suggest that AmpC and AmpH play roles in the normal course of peptidoglycan 2 
synthesis, remodeling, or recycling. Pbp4b has been shown to have a weak DD-carboxypeptide 3 
activity in vitro (Vega & Ayala, 2006), but extensive assays to identify any enzymatic activity with 4 
natural isolated muropeptides have been unsuccessful (unpublished results, J. Ayala). 5 
On the opposite, in B. subtilis, a weak β-lactamase activity is associated with PBP4* 6 
(Popham & Setlow, 1993). Dynamic localization of PBP4* and PBPX, in fusion with the green 7 
fluorescent protein (GFP), during spore development, has shown that PBP4* is implicated as 8 
having a function in sporulation. Moreover it was seen that PBPX changes its localization and 9 
accumulates specifically at the prespore. It starts by localizing to the division septum at midcell, 10 
and then appears to spiral out in a pattern similar to FtsZ. GFP-PBPX is seen to appear at both 11 
poles, as observed for cell-division proteins like FtsZ and the sporulation-specific SpoIIE. Despite 12 
these observations, PBPX does not seem to be an essential component of the cell-division 13 
machinery of B. subtilis. Indeed, the inactivation of PBPX does not affect cell growth, or cell shape 14 
or sporulation efficiency. A possible role for the PBPX could be the quick removal of PG 15 
connecting two cells after vegetative division, or thinning of the sporulation septum prior to 16 
engulfment (Scheffers, 2005).  17 
 18 
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Peptidoglycan manufacture 1 
 2 
Resting on the information reviewed in the previous chapters, and using a peptidoglycan model 3 
based on glycan chains running parallel to the cytoplasmic membrane, we propose a simplified 4 
version of the three-to-one model of peptidoglycan biosynthesis described by J. Höltje (Holtje, 5 
1998). The purpose of this model is to specify for each type of PBPs a role in peptidoglycan 6 
biosynthesis and in the incorporation of new glycan chains in the preexisting peptidoglycan (figure 7 
9A) (see chapter “Peptidoglycan Structure and Architecture” by W. Vollmer et al. for a review of 8 
peptidoglycan models)  9 
Lipid II is synthesized in the cytoplasm by the mur family enzymes (see chapter “Cytoplasmic steps 10 
of peptidoglycan biosynthesis” by H. Barreteau et al.) and then transferred to the class A PBP 11 
glycosyltransferase active site where it is transglycosylated onto a donor strand that may run along 12 
the surface of the whole class A PBP (figure 9B). The donor strand can adopt a three- or fourfold 13 
rotation axis (Holtje, 1998, Meroueh, et al., 2006)  while running along the class A PBP surface. 14 
The stem peptide of a disaccharide unit pentapeptide of the elongating strand (about nine 15 
disaccharide units from the glycosyltransferase active site) can insert into the groove of the 16 
penicillin-binding domain active site where it may undergo a transpeptidase attack from a 17 
preexisting peptidoglycan transpeptidase-donor strand (figure 9B). The orientation of the active site 18 
of the transpeptidase domain suggests that class A PBPs can hook the elongating glycan strand 19 
beneath the old peptidoglycan. 20 
Although class A PBPs have a transpeptidase domain, the transpeptidase domain of a class B PBP 21 
is needed. The precise role of each transpeptidase domain in peptidoglycan biosynthesis is not 22 
known and we hypothesize that class B PBPs undertake to cross-link the glycan chain hooked by 23 
class A PBPs beneath the old peptidoglycan to a second strand of the peptidoglycan (figure 9C). 24 
After hydrolysis by an endopeptidase of the bond that cross-links the two old glycan chains, the 25 
new strand reaches the surface as a result of the internal pressure. The endopeptidase activity of 26 
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type-4 or type-7 PBPs can serve to cleave the cross-links between the glycan chains (figure 10). 1 
These enzymes don’t need to be directly associated with the elongasome complex but they could be 2 
associated with other amidases.  3 
Type-5 PBPs removes the ultimate D-Ala of the pentapeptide. They seem not to be directly 4 
associated with the proteins of the divisome or the elongasome. They are dispersed on the whole 5 
surface and prevent the septum formation at inappropriate places by removing the pentapeptide 6 
substrates. The C-terminal domain can act as a pedestal that positions the penicillin-binding domain 7 
close to the D-Ala stem peptide end of the peptidoglycan (figure 11).  8 
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LEGENDS 1 
 2 
Figure 1: PBPs classification. 3 
Complete set of PBPs from 10 bacteria. Class A and class B subdivisions are adapted from Goffin 4 
& Ghuysen. Subdivisions of class C are explained in the text. The name of the PBP is given with its 5 
encoding gene (for most PBPs). Abbreviations for PBPs from other bacteria: PBP5fm: 6 
Enterococcus faecium PBP5; R39: DD-peptidase from Actinomadura R39; K15: DD-peptidase 7 
from Streptomyces K15; R61: DD-peptidase from Streptomyces R61. 8 
PBPs for which the X-ray structure has been determined are highlighted in orange.  9 
PDB codes: E. coli PBP4 (2EX2); E .coli PBP5 (1NZ0); E. faecium PBP5 (not deposited); B. 10 
subtilis PBP4a (1W5D); S. aureus PBP2 (2OLU); S. aureus PBP2a (1MWS); S. aureus PBP4 11 
(1TVF); S. pneumoniae PBP1a (TP domain 2C6W); S. pneumoniae PBP1b (TP domain 2BG1); S. 12 
pneumoniae PBP2x (1QME); S. pneumoniae PBP3 (1XP4); A. R39 (1W79); S. K15 (1SKF); S.  13 
R61 (3PTE); M. tuberculosis PBP7 (2BCF). 14 
 15 
 16 
Figure 2: Overview of PBPs structures. 17 
Examples of each class of PBPs. High molecular mass PBPs are on the left and low molecular mass 18 
PBPs are on the right. PB: penicillin binding domain, with either transpeptidase or 19 
carboxypeptidase or endopeptidase activity. GT: transglycosylase domain. 20 
 21 
Figure 3: Penicillin binding domain active site 22 
A: Penicillin binding domain and conserved motifs of the active site. The first motif SxxK is 23 
coloured yellow with black letters. The second motif SxN is coloured green with green letters. The 24 
third motif is coloured cyan with white letters. The glycine in the rear of the active site is coloured 25 
red. 26 
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 1 
B:  Penicillin binding domain active site (B. subtilis PBP4a) acylated by a peptidoglycan mimetic 2 
peptide. The dipeptide D-α-aminopimelyl-ε-D-alanine (magenta) is covalently linked to the active 3 
serine S*. OH indicates the oxyanion hole defined by the two backbone amine groups shown in 4 
dark blue. The released D-alanine is shown in orange.  5 
 6 
C: Penicillin binding domain active site (S. aureus PBP2a) acylated by benzylpenicillin. 7 
Benzylpenicillin and the active serine are shown in pink. The amide bond of benzylpenicillin side 8 
chain is wedged between strand β3 and the asparagine of the second motif (green). The carboxylate 9 
is hydrogen bonded to both hydroxyl group of the third motif (cyan).  10 
 11 
 12 
Figure 4: Structure of class A PBPs (S. aureus PBP2a) 13 
A: Overall view of the structure of S. aureus PBP2. The catalytic serine of the penicillin 14 
binding/transpeptidase domain is shown as a red sphere and the catalytic glutamic acid (E114 of 15 
motif 1) of the transglycosylase domain is shown as a green sphere. 16 
 17 
B: Transglycosylase active site with binding of the moenomycin molecule.The moenomycin is 18 
shown in orange and the two putative catalytic residues E114 (green) and E171 (cyan) are shown in 19 
stick form. 20 
 21 
Figure 5: Structure of class B PBPs (E. faecium PBP5) 22 
Overall view of the structure of E. faecium PBP5. The catalytic serine of the penicillin 23 
binding/transpeptidase domain is shown as a red sphere. The subdomai in ellow is delimited by the 24 
N-terminal helix and motif I. The red, green and blue sudomains are respectively delimited by 25 
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motifs I and II, motifs II and III, and motifs III and IV. The subdomain in orange is inserted in the 1 
penicillin binding domain between motif V and the active serine (motif 1 of the PB domain)  2 
 3 
 4 
Figure 6: Structure of type-4 PBPs (B. subtilis PBP4a) 5 
Overall view of the structure of B. subtilis PBP4a. The catalytic serine of the penicillin 6 
binding/endopeptidase domain is shown as a red sphere.  Seven lysine residues  (Lys83, Lys85, 7 
Lys86, Lys114, Lys119, Lys122 and Lys265) forming a  positively charged surface in domain II are 8 
represented as blue sticks. 9 
 10 
Figure 7: Structures of type-5 PBPs (E. coli PBP5) and type-7 PBPs (S. K15) 11 
Overall view of the structures of E. coli PBP5 (A) and S. K15 (B). The catalytic serine of the 12 
penicillin binding/DD-peptidase domain is shown as a red sphere.  On the top of both active sites 13 
the β-hairpin protuberance is coloured in green.  14 
 15 
Figure 8: Structures of type-AmpH PBPs (S. R61) and the D-aminopeptidase (O.  anthropi) 16 
Overall view of the structures of S. R61 (A) and the D-aminopeptidase from O.  anthropi (B). The 17 
catalytic serine of the penicillin binding/peptidase domain is shown as a red sphere.  The two 18 
additional β-barrels domains of the D-aminopeptidase are oriented in the front of the penicillin-19 
binding domain, and the loop impairing the active site entrance is highlighted in green.  20 
 21 
Figure 9: Role of PBPs in biosynthesis 22 
A: Overview of glycan chain synthesis and its incorporation in old peptidoglycan. The pre-existing 23 
peptidoglycan is shown in blue. The glycan chain newly synthesized is shown in green. The glycan 24 
chain is elongated by incorporation of lipid II in the glycosytransferase domain of the class A PBP 25 
(yellow). Transpeptidation between the glycan chain and the old peptidoglycan occurs both in the 26 
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transpeptidase domain of the class A PBP and the transpeptidase domain of the class B PBP 1 
(magenta). The new chain is incorporated after endopeptidation of the pre-existing peptidoglycan 2 
by the type-4 PBP (orange). CM: cytoplasmic membrane (Heller, et al., 1993). OM: Outer 3 
membrane. PG: peptidoglycan.    4 
 5 
B: The elongating glycan chain running along the surface of a classA PBP and its attachment to the 6 
preexisting peptidoglycan. 7 
 8 
C: Transpeptidation by a class B PBP of a glycan chain. The new glycan chain (green) previously 9 
hooked to the old peptidoglycan by a class A PBP is transpeptidated by a class B PBP. 10 
 11 
Figure 10: Endopeptidation by type-4 PBP 12 
View of the peptidoglycan from the cytoplasmic membrane side. The type-4 PBP (orange) can 13 
hydrolyze the cross-link between two glycan chains. The active site is shown with a white arrow. 14 
 15 
Figure 11 DD-carboxypeptidation by a type-5 PBP. 16 
Type-5 PBP can remove the D-alanine from the pentapeptide. Type-5 PBP is coloured pink. CM: 17 
cytoplasmic membrane. OM: Outer membrane. PG: peptidoglycan.    18 
 19 
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Table 1 
 
 kcat (s
-1) Km (µM) kcat/Km (M
-1s-1) references 
A-PBPs     
PBP1b_Eco 0.64 
70 10-3 
2 
1.8 
3.2 105 
3.9 104 
(Schwartz, et al., 2002) 
(Terrak, et al., 1999) 
PBP1a_Eco 0.03 1 3.3 104 (Mottl, et al., 1995) 
PBP2_Sau 1.5 10-2 4 3.4 103 (Barrett, et al., 2005) 
PBP4_Lmo - > 5 1.4  103 (Zawadzka-Skomial, et al., 2006) 
PBP2a_Spn 4.3 10-8 40.6 1.0 10-3 (Di Guilmi, et al., 2003) 
A-GTs     
PBP1b_Eco 
M1-S409 
M1-L433 
 
0.83 10-2  
2 10-2 
 
0.87 
2.6 
 
9700 
7700 
(Barrett, et al., 2004) 
PBP1_Aae  0.058 5.8 1.0 104 (Yuan, et al., 2007) 
PBP1b_Spn  0.76 62 1.2 104 (Liu & Wong, 2006) 
     
MGTs     
MGT_Sau 13 10-3 2.2 5.8 103 (Terrak & Nguyen-Disteche, 2006) 
     
Eco = E. coli; Sau = S. aureus; Lmo = L. monocytogenes; Spn = S. pneumoniae; Aae = A. aeolicus. 
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